News from arena pharmaceuticals, inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

May 28, 2020, 08:30 ET Arena Pharmaceuticals Announces Pricing of Public Offering of Common Stock

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced the pricing of an underwritten public offering of 5,500,000 shares of its common stock at...

May 27, 2020, 16:01 ET Arena Pharmaceuticals Announces Proposed Public Offering of Common Stock

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that it intends to offer and sell, in an underwritten public offering and subject to...

May 26, 2020, 08:30 ET Arena Completes Full Enrollment of Etrasimod Phase 2 ADVISE Trial for Atopic Dermatitis, Provides Program Updates

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that it has completed full enrollment of the Phase 2b ADVISE trial evaluating etrasimod,...

May 22, 2020, 16:30 ET Arena Announces Change to Virtual Format for 2020 Annual Meeting of Stockholders

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that, due to public health and safety concerns related to the COVID-19 global pandemic,...

May 20, 2020, 16:01 ET Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that on May 15, 2020, the Compensation Committee of its Board of Directors granted...

May 13, 2020, 16:01 ET Arena Pharmaceuticals to Participate in Upcoming Investor Conferences

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that members of its senior management team will participate in two upcoming investor...

May 07, 2020, 16:01 ET Arena Announces Corporate Update and Reports First Quarter 2020 Financial Results

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today provided a corporate update and reported financial results for the first quarter ended March 31,...

May 06, 2020, 08:30 ET Arena Pharmaceuticals to Present at the Bank of America Securities Healthcare Conference on May 13

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that Preston Klassen, MD, MHS, the Company's Executive Vice President, Head of Research &...

Apr 30, 2020, 08:30 ET Arena Pharmaceuticals to Release First Quarter 2020 Financial Results and Provide Corporate Update on May 7

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) will release its first quarter 2020 financial results and provide a corporate update on Thursday, May 7,...

Apr 24, 2020, 09:00 ET Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that on April 15, 2020, the Compensation Committee of its Board of Directors granted...

Apr 10, 2020, 13:09 ET Arena Pharmaceuticals to Present at the 19th Annual Needham Virtual Healthcare Conference on April 14

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that Amit D. Munshi, the Company's President and Chief Executive Officer, is scheduled to...

Apr 01, 2020, 16:01 ET Arena Pharmaceuticals Announces Positive Topline Data for New Development Program - Etrasimod Controlled-Release (CR)

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced positive topline data from a Phase 1 clinical study evaluating controlled-release delivery ...

Mar 30, 2020, 08:30 ET Arena Pharmaceuticals Names James C. Mullen as an Independent Senior Advisor

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that James C. Mullen has agreed to serve as an independent senior advisor to the Company....

Mar 18, 2020, 16:01 ET Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that on March 12, 2020, the Compensation Committee of its Board of Directors approved...

Feb 26, 2020, 16:01 ET Arena Announces Management and Program Updates and Reports Fourth Quarter and Full-Year 2019 Financial Results

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today provided a corporate update and reported financial results for the fourth quarter and full-year...

Feb 21, 2020, 16:11 ET Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that on February 10, 2020 the Compensation Committee of its Board of Directors granted...

Feb 20, 2020, 08:30 ET Arena Pharmaceuticals to Present at the Upcoming Investor Conferences

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that Amit D. Munshi, President and Chief Executive Officer, will present at the upcoming...

Feb 19, 2020, 16:06 ET Arena Pharmaceuticals to Release Fourth Quarter & Full-Year 2019 Financial Results and Provide Corporate Update on February 26

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) will release its fourth quarter and full-year 2019 financial results and provide a corporate update on...

Feb 11, 2020, 15:06 ET Arena Pharmaceuticals' Presence at the European Crohn's and Colitis Organisation (ECCO) Congress Further Highlights Commitment to the GI Community

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced it will present new data from the open-label extension (OLE) of the Phase 2 OASIS trial...

Jan 16, 2020, 09:00 ET FDA Grants Fast Track Designation to Arena Pharmaceuticals' APD418 for Development in Decompensated Heart Failure Patients

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that the U.S. Food and Drug Administration (FDA) granted Fast Track designation for...

Jan 13, 2020, 16:01 ET Arena Pharmaceuticals Appoints Joan Schmidt as Executive Vice President, General Counsel and Secretary

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) announced today the appointment of Joan Schmidt as Executive Vice President, General Counsel and Secretary....

Jan 08, 2020, 08:30 ET Arena Pharmaceuticals to Present at the 38th Annual J.P. Morgan Healthcare Conference on January 16

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that Amit D. Munshi, the Company's President and Chief Executive Officer, will present a...

Jan 06, 2020, 16:01 ET Arena Pharmaceuticals Highlights Strategic Plan Driving Near and Long-term Growth with Eight Ph 2 and Ph 3 Data Readouts in 2020-21 and One New IND Per Year for the Next 5 Years

rena Pharmaceuticals, Inc. (Nasdaq: ARNA) will provide a corporate update highlighting its strategic portfolio expansion on a conference call...

Nov 26, 2019, 08:30 ET Arena Pharmaceuticals to Participate in Upcoming Investor Conferences

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that members of its senior management team will participate at the upcoming investor...

Nov 18, 2019, 16:01 ET California Life Sciences Association Honors Arena Pharmaceuticals at the Pantheon 2019 DiNA™ Awards for the Deal of the Year

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) was honored by the California Life Sciences Association (CLSA) with the Pantheon 2019 DiNA™ Deal of the...